# Renal Denervation With Sterile Irrigated Deflectable Ablation Catheter Used in Renal Artery in Primary Hypertension

Study · id `cardio:ct-nct03511313` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03511313](<https://clinicaltrials.gov/study/NCT03511313>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03511313

Browse, organ or system: Blood vessels  
Browse, condition area: High blood pressure  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 264 participants.

## Technical summary

Registry record NCT03511313. Randomized; single masking; primary purpose treatment. Start 2018-04-11 (actual); primary completion 2020-06 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 264 participants (planned count; ClinicalTrials.gov record NCT03511313, source copy `cardio:ctgov-nct03511313-2018-04-27`, retrieved 2026-10-26)
- Started: 2018-04-11 (actual) (ClinicalTrials.gov record NCT03511313, source copy `cardio:ctgov-nct03511313-2018-04-27`, retrieved 2026-10-26)
- Primary completion: 2020-06 (anticipated) (ClinicalTrials.gov record NCT03511313, source copy `cardio:ctgov-nct03511313-2018-04-27`, retrieved 2026-10-26)
- Completion: 2020-09 (anticipated) (ClinicalTrials.gov record NCT03511313, source copy `cardio:ctgov-nct03511313-2018-04-27`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT03511313, source copy `cardio:ctgov-nct03511313-2018-04-27`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03511313-2018-04-27`, retrieved 2026-10-26)

## The registry's words

- Brief title: Renal Denervation With Sterile Irrigated Deflectable Ablation Catheter Used in Renal Artery in Primary Hypertension
- Condition: Primary Hypertension
- Intervention (Device): Renal denervation
- Intervention (Diagnostic test): Renal angiography
- Lead sponsor: Synaptic Medical Corporation
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Hypertension (high blood pressure) (`core:hypertension`)

## Provenance

Content hash: 1c1d63b9bb58e3d7c47bbf216ef070587a28531691ff07f85bc2218e5c17bc47
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
